Skip to Content

Potassium Acetate Injection

Last Updated: February 27, 2017
Status: Resolved

Products Affected - Description
    • Potassium acetate injection, American Regent, 2 mEq/mL, 20 mL vial, 25 count, NDC 00517-2053-25
    • Potassium acetate injection, American Regent, 4 mEq/mL, 50 mL vial, 25 count, NDC 00517-5024-25
Reason for the Shortage
    • American Regent has potassium acetate on long-term shortage due to manufacturing delays. It is unclear if and when product will return to market
    • Pfizer has potassium acetate injection available.
    • Exela received FDA approval for potassium acetate injection in late-December 2015. Exela has potassium acetate injection available.
Available Products
    • Potassium acetate injection, Exela Pharma Sciences, 2 mEq/mL, 20 mL vial, 25 count, NDC 51754-2001-04
    • Potassium acetate injection, Pfizer, 2 mEq/mL, 20 mL vial, 25 count, NDC 00409-8183-01
    • Potassium acetate injection, Pfizer, 2 mEq/mL, 50 mL vial, 25 count, NDC 00409-3924-51

Estimated Resupply Dates

    • American Regent has potassium acetate 2 mEq/mL 20 mL vials and 4 mEq/mL 50 mL vials on long-term back order and the company cannot estimate a release date.
    • All other marketed presentations are available.

Updated

Updated February 27, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. Created December 30, 2015 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide